Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytochrome P450 polymorphisms are associated with reduced warfarin dose.

B D Freeman1, B A Zehnbauer, S McGrath

  • 1Departments of Surgery, Pathology, and Biostatistics, Washington University School of Medicine, St Louis, MO 63110, USA.

Surgery
|August 3, 2000
PubMed
Summary

Cytochrome P450 (CYP) gene polymorphisms are common in patients taking warfarin, affecting drug metabolism and sensitivity. Genotyping can help determine more accurate warfarin doses, improving treatment safety and effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PAR2 deletion in the osteoblast lineage affords long-term cartilage protection in experimental osteoarthritis.

Osteoarthritis and cartilage·2026
Same author

Safety and Efficacy of Atezolizumab in Combination With nab-Paclitaxel in Patients With PD-L1 Positive Metastatic or Locally Advanced Triple-Negative Breast Cancer: A UK-Wide Cancer Centre Experience.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Periparturient mortality in merino ewes in Australia: Incidence, impact and the path to mitigation strategies.

Australian veterinary journal·2025
Same author

Evaluating the effect of calcium, magnesium and sodium supplementation of Merino ewes on their lambs' growth.

Australian veterinary journal·2023
Same author

Assessment of cannabidiol use in pets according to a national survey in the USA.

The Journal of small animal practice·2023
Same author

Moderate exercise protects against joint disease in a murine model of osteoarthritis.

Frontiers in physiology·2022

Area of Science:

  • Pharmacogenomics
  • Drug Metabolism
  • Genetics

Background:

  • Warfarin dosing exhibits significant interpatient variability.
  • Cytochrome P450 (CYP) enzyme polymorphisms are implicated in variable warfarin response.
  • Understanding CYP genotype influence is crucial for optimizing warfarin therapy.

Purpose of the Study:

  • To determine the frequency of CYP2C9 and CYP2A6 polymorphisms in a patient population.
  • To evaluate the impact of these polymorphisms on warfarin dosage requirements.

Main Methods:

  • Genotyping for CYP2C9 (*1, *2, *3) and CYP2A6 (*1, *2) alleles using polymerase chain reaction.
  • Recruitment of patients receiving warfarin therapy from hospital inpatient divisions.
  • Statistical comparison of genotypes using an unpaired t test.

Related Experiment Videos

Main Results:

  • CYP2C9 and CYP2A6 polymorphisms were identified in 34% of the 38 patients studied.
  • Carriers of CYP2C9*2, CYP2C9*3, or CYP2A6*2 alleles required significantly lower weekly warfarin doses compared to wild-type.
  • Mean weekly warfarin dose was reduced in patients with variant alleles (0.307 mg/kg/wk) versus wild-type (0.397 mg/kg/wk).

Conclusions:

  • Impaired warfarin metabolism due to CYP polymorphisms is prevalent.
  • These genetic variations are linked to increased warfarin sensitivity.
  • Incorporating genotypic data into warfarin prescribing can enhance medication safety and efficacy.